Project Grant R01DA059961
Award Date
9/30/24
Completion Date
5/31/29
Dollars Obligated
$2M
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55455, USA
Similar Awards
This $2,118,992 Project Grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a longitudinal study investigating the neural and psychiatric consequences of cannabis use in depressed adolescents. The research aims to prospectively examine the effects of cannabis, the most widely used illicit drug among teenagers, on reward and pain neurocircuits in adolescents with depression. The study will evaluate 250...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding a $621,186 longitudinal study to examine the impact of circulating endocannabinoid levels on neurocognition, impulsivity, and early cannabis use patterns in youth enrolled in the Adolescent Brain Cognitive Development (ABCD) study. The 5-year study, running from July 2025 to March 2030, will be conducted by the University of...
This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
This federal Project Grant award of $360,100.00 was provided by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), to George Washington University. The funding will support research on the "Socio-Structural Determinants of Cannabis and Derived Psychoactive Cannabis Product Use and Consequences Among Young Adults." The project aims to investigate the increasing use of cannabis and derived psychoactive cannabis products,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a 5-year, $2,726,432 research study on co-use of cannabis and prescription opioids among emerging adults in medical settings. The study will enroll emerging adults aged 18-25 who either have no history of cannabis use or have used cannabis in the past month and are prescribed an opioid for acute pain management. Participants will be followed...
This four-year, $4.6 million project grant from the National Institute on Drug Abuse will fund research at the University of Miami exploring the linkage between cannabis use, route of administration, cannabinoid content, and measures of cardiovascular disease (CVD) risk in people living with HIV (PWH). Specifically, the principal investigator - an interventional cardiologist and physician scientist focused on HIV and CVD prevention - will collect comprehensive data on 300 PWH ages 18-60 to...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,383,618.00 in funding to The Johns Hopkins University to conduct research on the microglia-mediated adverse effects of cannabis (specifically delta-9-tetrahydrocannabinol or THC) on the maturation of the prefrontal cortex and cognitive function during adolescence. The research aims to elucidate the molecular and cellular mechanisms by which THC...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 Drug Use and Addiction Research Programs, provides $3,487,935 to Florida State University to conduct a study examining the effects of long-term medical marijuana use and prescription opioid use on driving performance in adults aged 50 and older with chronic pain. The primary goals are to identify the impacts of daily, long-term medical marijuana use on open-road driving tasks, as well as the...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the impact of prenatal exposure to cannabis on childhood adiposity and cardiometabolic health outcomes. The $234,000 award, with a performance period from August 2024 to July 2026, will support a study using a well-characterized observational cohort in Colorado to measure the levels of delta-9-tetrahydrocannabinol (D9-THC) and...
This Project Grant award of $443,263 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to characterize the unique effects of recreational cannabis use on sleep in women of childbearing age. The 5-year study, beginning September 2024, will examine the relationship between cannabis use and sleep, investigating the mediating role of stress physiology and reproductive hormones. The research will utilize a within-subject design...